carbamazepine has been researched along with Fatty Liver in 4 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 42-year-old woman presented with acute bullous skin lesions and angio-oedema that had developed 3 months after initiation of treatment with carbamazepine for epilepsy." | 3.71 | Non-alcoholic steatohepatitis induced by carbamazepine and variegate porphyria. ( Alfei, B; Bianco, A; Biolcati, G; Di Rocco, P; Gasbarrini, G; Grieco, A; Griso, D; Miele, L; Vecchio, FM, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, CW | 1 |
| Zhang, H | 1 |
| Li, M | 1 |
| Xiong, X | 1 |
| Chen, X | 2 |
| Dong, XC | 1 |
| Yin, XM | 1 |
| Friedman, SL | 1 |
| Luef, GJ | 1 |
| Waldmann, M | 1 |
| Sturm, W | 1 |
| Naser, A | 1 |
| Trinka, E | 1 |
| Unterberger, I | 1 |
| Bauer, G | 1 |
| Lechleitner, M | 1 |
| Grieco, A | 1 |
| Alfei, B | 1 |
| Di Rocco, P | 1 |
| Miele, L | 1 |
| Biolcati, G | 1 |
| Griso, D | 1 |
| Vecchio, FM | 1 |
| Bianco, A | 1 |
| Gasbarrini, G | 1 |
4 other studies available for carbamazepine and Fatty Liver
| Article | Year |
|---|---|
Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice.
Topics: Animals; Autophagy; Biomarkers; Carbamazepine; Cells, Cultured; Chloroquine; Dietary Fats; Disease M | 2013 |
Focus.
Topics: Animals; Autophagy; Carbamazepine; Fatty Liver; Fatty Liver, Alcoholic; Non-alcoholic Fatty Liver Di | 2013 |
Valproate therapy and nonalcoholic fatty liver disease.
Topics: Adolescent; Adult; Carbamazepine; Chi-Square Distribution; Epilepsy; Fatty Liver; Female; Humans; Ma | 2004 |
Non-alcoholic steatohepatitis induced by carbamazepine and variegate porphyria.
Topics: Adult; Anticonvulsants; Carbamazepine; Chemical and Drug Induced Liver Injury; Diagnosis, Differenti | 2001 |